Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [815]
News [1669]
Articles [253]
Editorials [5]
Conferences [138]
elearning [32]
National clinical trial provides mastectomy alternative for recurrent breast cancer
National clinical trial provides mastectomy alternative for recurrent breast cancer
SABCS 2019: Breast biopsies after neoadjuvant chemotherapy accurately predict presence of residual breast cancer
SABCS 2019: Breast biopsies after neoadjuvant chemotherapy accurately predict presence of residual breast cancer
SABCS 2019: Breast-conserving treatment without surgery not supported at this time
SABCS 2019: Breast-conserving treatment without surgery not supported at this time
SABCS 2019: Predicting triple negative breast cancer recurrence
SABCS 2019: Predicting triple negative breast cancer recurrence
Standard pathology tests outperform molecular subtyping in bladder cancer
Standard pathology tests outperform molecular subtyping in bladder cancer
SABCS 2019: Residual cancer burden can predict outcomes for patients with any breast cancer type
SABCS 2019: Residual cancer burden can predict outcomes for patients with any breast cancer type
SABCS 2019: Circulating tumour DNA may help predict recurrence in patients with early triple-negative breast cancer
SABCS 2019: Circulating tumour DNA may help predict recurrence in patients with early triple-negative breast cancer
SABCS 2019: Partial breast irradiation may be as effective as whole breast irradiation in preventing recurrence in patients with early breast cancer
SABCS 2019: Partial breast irradiation may be as effective as whole breast irradiation in preventing recurrence in...
SABCS 2019: Neoadjuvant and adjuvant treatment with pembrolizumab improves pathologic complete response rates for patients with triple-negative breast cancer with lymph node involvement
SABCS 2019: Neoadjuvant and adjuvant treatment with pembrolizumab improves pathologic complete response rates for...
SABCS 2019: Updated APHINITY trial data show addition of pertuzumab to trastuzumab plus chemotherapy continues to yield clinical benefit in patients with operable HER2-positive early breast cancer
SABCS 2019: Updated APHINITY trial data show addition of pertuzumab to trastuzumab plus chemotherapy continues to...

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation